Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PE0139 in type 2 diabetes mellitus
NCT02581657Phase 2Completed
- Sponsor
- PhaseBio Pharmaceuticals
- Start
- Oct 2015
- Primary completion
- Nov 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of pe0139 in type 2 diabetes mellitus (T2DM), sponsored by PhaseBio Pharmaceuticals. Started Oct 2015; status: completed.
02
Drugs
pe0139
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02581657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02581657.